Celcuity Inc.
NASDAQ:CELCBiotechnology
-$4.04 today
- Market cap
- $2.72B
- Beta
- 0.12
- P/E (TTM)
- -23.7
- EPS (TTM)
- -$3.54
Volume 0.98M
Average 1.24M
CELC Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Celcuity Inc.NASDAQ: CELC
Deferred Revenue · Q2 FY2026 · quarter ended Jun 2026
Deferred revenue remains negative
Q2 FY2026 deferred revenue was $0, compared with $0 a year earlier.
Context
- Deferred revenue amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Deferred revenue increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Deferred Revenue vs competitors
How CELC compares with its peers on the latest reported figures
- CELC's Jun 2026 deferred revenue of $0 is the 4th highest of the 6 companies compared; the peer median is $2.33M.
- Deferred revenue amounts to 0.0% of total assets for CELC, versus a peer median of 0.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $53.26M | -3.7% | -11.0% | 8.3% | |
| Mar 2026 | $4.17M | +112.2% | +6.5% | 1.3% | |
BLLNBillionToOne, Inc. | Jun 2026 | $2.33M | +5.1% | — | 0.3% |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | -100.0% | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CELC) | $2.33M | +0.7% | -2.3% | 0.3% | |
Competitors are the stored peer set for CELC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 84.29M | 24.57M | 30.66M | 22.51M | 165.7M |
| Short-term Investments | 0 | 144.02M | 149.92M | 212.59M | 275.79M |
| Net Receivables | 298.76K | 203.67K | 805.88K | 1.6M | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 22.14K | 22.01K | 281.36K | 841.33K | 24.16M |
| Total Current Assets | 85.35M | 175.16M | 190.59M | 244.57M | 465.66M |
| Property, Plant & Equipment (Net) | 554.35K | 506.56K | 628.8K | 552.02K | 550K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 33.2K | 0 | 0 | 349K |
| Total Non-current Assets | 554.35K | 539.76K | 628.8K | 552.02K | 899K |
| Total Assets | 85.91M | 175.7M | 191.22M | 245.12M | 466.56M |
| Account Payables | 1.51M | 2.63M | 5.08M | 9.37M | 6.41M |
| Short-term Debt | 0 | 194.2K | 0 | 0 | 54K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 472.93K | 3.09M | 7.11M | 0 | 37.69M |
| Total Current Liabilities | 2.51M | 6.88M | 14.19M | 31.72M | 44.15M |
| Long-term Debt | 14.63M | 34.98M | 37.04M | 97.73M | 195.32M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 126.53M |
| Total Non-current Liabilities | 14.69M | 35.04M | 37.26M | 97.78M | 321.85M |
| Total Liabilities | 17.2M | 41.93M | 51.45M | 129.5M | 366M |
| Common Stock | 14.92K | 21.67K | 25.51K | 37.14K | 48K |
| Retained Earnings | (55.93M) | (96.3M) | (160.08M) | (271.86M) | (448.9M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 68.71M | 133.77M | 139.77M | 115.62M | 100.56M |
| Total Debt | 14.89M | 35.24M | 37.45M | 97.95M | 195.38M |
| Net Debt | (69.4M) | 10.67M | 6.78M | 75.44M | 29.68M |
Celcuity Inc.
NASDAQ:CELC
Intrinsic Alpha fair value
Locked
Current Price
$55.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.